ERBB2 and urinary bladder carcinoma: HER2 is overexpressed in multiple solid tumors including breast (BC), colorectal (CRC), gastric (GC), gastroesophageal junction (GEJC), non-small-cell lung (NSCLC), biliary tract (BTC), and bladder cancers.